Nephrology News

ORLANDO — In the 7 years since 2015, nephrologists have showed a 35-fold increased use of SGLT2 inhibitors, according to a presenter at ASN Kidney Week.

PHILADELPHIA — Half of patients with systemic lupus erythematosus and new-onset, low-grade proteinuria progress to clinical proteinuria within 2 years, according to results of a study presented at ACR Convergence 2022.

BOSTON — Masked hypertension is an underappreciated phenomenon that confers extra risk for CVD and chronic kidney disease, and simple steps such as home BP monitoring and stepped-up medications can improve outcomes, according to a speaker.

BOSTON — In this Healio video exclusive, Juan P. Frias, MD, discusses his presentation on newer treatment options for type 2 diabetes at the Cardiometabolic Health Congress.

The American Association of Clinical Endocrinology has issued a grade-A recommendation to use Kerendia for certain patients with chronic kidney disease associated with type 2 diabetes.

For intermediate- and high-risk patients with chronic kidney disease in primary care clinics, there are “several areas” for care improvement, according to data published in the American Journal of Kidney Diseases.

In middle-aged women, kidney function declined slower than it did in men the same age or older during aging, according to a study in the Journal of the American Society of Nephrology.

LAS VEGAS — Disparities in stroke care, particularly among underrepresented populations, can be overcome through educational efforts in both the health care system and at the community level, said a presenter at BRAINWeek 2022.

Among patients with chronic kidney disease, the more medication prescriptions one has is associated with poor nutritional status, according to data published in the Journal of Renal Nutrition.

A new report from the Milken Institute recommends that health officials prioritize identification of the root causes of health inequity that contribute to kidney disease in efforts to slow down its occurrence.